← Back to Search

Sound Coding Strategies for Hearing Loss

N/A
Recruiting
Led By David M Landsberger, MD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be ages 18 or older and post-lingually implanted or have normal hearing.
Be ages 18-35 and pre-lingually implanted.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline visit (day 1) , visit week 10
Awards & highlights
No Placebo-Only Group

Summary

This trial is studying how well cochlear implants work and if they improve sound perception. They will compare information from people with and without cochlear implants.

Who is the study for?
This trial is for children and adults with cochlear implants implanted before age 2, those who have some hearing left with aids, or normal hearing. It's open to ages 7-35 if pre-lingually implanted and 18+ for post-lingual implantation or normal hearing. Post-lingually implanted children cannot participate.
What is being tested?
The study tests how different sound coding strategies in cochlear implants affect auditory performance. Participants will try electric-only spectral resolution methods and single-electrode pulse trains to see which improves sound perception.
What are the potential side effects?
Since this trial involves non-invasive auditory testing rather than medication or surgery, there are minimal side effects expected. Some participants might experience fatigue or discomfort from wearing the testing equipment.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 or older with either a cochlear implant received after learning to speak or normal hearing.
Select...
I am between 18 and 35 years old and received my implant before I could speak.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline visit (day 1) , visit week 10
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline visit (day 1) , visit week 10 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in loudness growth in Cochlear Implant participants
Change in spectral resolution in Cochlear implant participants
Change in temporal resolution in Cochlear implant participants
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

6Treatment groups
Experimental Treatment
Active Control
Group I: Late Adult Cochlear Implant (LateAdultCI)Experimental Treatment3 Interventions
Post-lingually implanted adults, 18+ years
Group II: Early Child Cochlear Implant (EarlyChildCI)Experimental Treatment3 Interventions
Early implanted children, ages 7-17 years
Group III: Early Adult Cochlear Implant (EarlyAdultCI)Experimental Treatment2 Interventions
Early implanted adults, ages 18 to 35 years
Group IV: Cochlear Implant (CI)Experimental Treatment1 Intervention
CI children, ages 7-17 years, with aided residual hearing (bimodal/contralateral, electric+acoustic/ipsilateral)
Group V: Normal Hearing Adults (NHA)Active Control1 Intervention
18+ years, Control Group
Group VI: Normal Hearing Children (NHC)Active Control1 Intervention
Ages 7-17 years, Control Group

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,409 Previous Clinical Trials
855,395 Total Patients Enrolled
17 Trials studying Hearing Loss
2,204 Patients Enrolled for Hearing Loss
David M Landsberger, MDPrincipal InvestigatorNYU Langone Health

Media Library

Cochlear Implant Clinical Trial Eligibility Overview. Trial Name: NCT05203302 — N/A
Hearing Loss Research Study Groups: Normal Hearing Adults (NHA), Late Adult Cochlear Implant (LateAdultCI), Early Child Cochlear Implant (EarlyChildCI), Early Adult Cochlear Implant (EarlyAdultCI), Cochlear Implant (CI), Normal Hearing Children (NHC)
Hearing Loss Clinical Trial 2023: Cochlear Implant Highlights & Side Effects. Trial Name: NCT05203302 — N/A
Cochlear Implant 2023 Treatment Timeline for Medical Study. Trial Name: NCT05203302 — N/A
~2 spots leftby Jan 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top